NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine; National Academy of Sciences; Committee on Human Gene Editing: Scientific, Medical, and Ethical Considerations. Human Genome Editing: Science, Ethics, and Governance. Washington (DC): National Academies Press (US); 2017 Feb 14.
Human Genome Editing: Science, Ethics, and Governance.
Show details- R. ALTA CHARO (Co-Chair), Sheldon B. Lubar Distinguished Chair and Warren P. Knowles Professor of Law and Bioethics, University of Wisconsin–Madison
- RICHARD O. HYNES (Co-Chair), Investigator, Howard Hughes Medical Institute; Daniel K. Ludwig Professor for Cancer Research, Massachusetts Institute of Technology
- DAVID W. BEIER, Managing Director, Bay City Capital
- ELLEN WRIGHT CLAYTON, Craig Weaver Professor of Pediatrics, Professor of Law, Vanderbilt University
- BARRY S. COLLER, David Rockefeller Professor of Medicine, Physician in Chief, and Head, Allen and Frances Adler Laboratory of Blood and Vascular Biology, The Rockefeller University
- JOHN H. EVANS, Professor, University of California, San Diego
- JUAN CARLOS IZPISUA BELMONTE, Professor, Gene Expression Laboratory, Salk Institute for Biological Studies
- RUDOLF JAENISCH, Professor of Biology, Massachusetts Institute of Technology
- JEFFREY KAHN, Andreas C. Dracopoulos Director, Johns Hopkins Berman Institute of Bioethics, Johns Hopkins University
- EPHRAT LEVY-LAHAD, Director, Fuld Family Department of Medical Genetics, Shaare Zedek Medical Center; Faculty of Medicine, Hebrew University of Jerusalem
- ROBIN LOVELL-BADGE, Senior Group Leader, Laboratory of Stem Cell Biology and Developmental Genetics, The Francis Crick Institute
- GARY MARCHANT, Regents' Professor of Law, Lincoln Professor of Emerging Technologies, Arizona State University
- JENNIFER MERCHANT, Professor, Université de Paris II (Panthéon-Assas)
- LUIGI NALDINI, Professor of Cell and Tissue Biology and of Gene and Cell Therapy, San Raffaele University, and Scientific Director of the San Raffaele Telethon Institute for Gene Therapy
- DUANQING PEI, Professor and Director General of Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
- MATTHEW PORTEUS, Associate Professor of Pediatrics, Stanford University School of Medicine
- JANET ROSSANT, Senior Scientist and Chief of Research Emeritus, Hospital for Sick Children, University of Toronto
- DIETRAM A. SCHEUFELE, John E. Ross Professor in Science Communication and Vilas Distinguished Achievement Professor, University of Wisconsin–Madison
- ISMAIL SERAGELDIN, Founding Director, Bibliotheca Alexandrina
- SHARON TERRY, President and CEO, Genetic Alliance
- JONATHAN WEISSMAN, Professor, Department of Cellular and Molecular Pharmacology, University of California, San Francisco; Investigator, Howard Hughes Medical Institute
- KEITH R. YAMAMOTO, Vice Chancellor for Science Policy and Strategy, Vice Dean for Research for the School of Medicine, Professor, University of California, San Francisco
Study Staff
- KATHERINE W. BOWMAN, Study Director
- MONICA L. GONZALEZ, Associate Program Officer
- JOANNA R. ROBERTS, Senior Program Assistant
- ANDREW M. POPE, Director, Board on Health Sciences Policy
- FRANCES E. SHARPLES, Director, Board on Life Sciences
Consultants
- RONA BRIERE, Editor
- HELAINE RESNICK, Editor
- COMMITTEE ON HUMAN GENE EDITING: SCIENTIFIC, MEDICAL, AND ETHICAL CONSIDERATIONS...COMMITTEE ON HUMAN GENE EDITING: SCIENTIFIC, MEDICAL, AND ETHICAL CONSIDERATIONS - Human Genome Editing
Your browsing activity is empty.
Activity recording is turned off.
See more...